p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-independent Penile Squamous Cell Carcinomas With Adverse Prognosis
- PMID: 39654380
- DOI: 10.1097/PAS.0000000000002341
p53 Immunohistochemistry Defines a Subset of Human Papillomavirus-independent Penile Squamous Cell Carcinomas With Adverse Prognosis
Conflict of interest statement
Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.
References
-
- Tekin B, Guo R, Erickson LA, et al. Re: p53 immunohistochemistry defines a subset of human papillomavirus-independent penile squamous cell carcinomas with adverse prognosis. Am J Surg Pathol. 2024;48:1439–1447.
-
- Tekin B, Cubilla AL, Cheville JC, et al. High-risk human papilloma virus status & outcomes for penile squamous cell carcinoma: a single institution experience. Hum Pathol. 2024;150:9–19.
-
- Trias I, Algaba F, de Torres I, et al. p53 immunohistochemistry defines a subset of human papillomavirus-independent penile squamous cell carcinomas with adverse prognosis. Am J Surg Pathol. 2024;48:1439–1447.
-
- Djajadiningrat RS, Jordanova ES, Kroon BK, et al. Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome. J Urol. 2015;193:526–531.
-
- Chahoud J, Zacharias NM, Pham R, et al. Prognostic significance of p16 and its relationship with human papillomavirus status in patients with penile squamous cell carcinoma: results of 5 years follow-up. Cancers (Basel). 2022;14:6024.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
